The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 09, 2013

Filed:

Jun. 25, 2009
Applicants:

Amy Ripka, Reading, MA (US);

Gideon Shapiro, Gainesville, FL (US);

Richard Chesworth, Boston, MA (US);

Inventors:

Amy Ripka, Reading, MA (US);

Gideon Shapiro, Gainesville, FL (US);

Richard Chesworth, Boston, MA (US);

Assignee:

EnVivo Pharmaceuticals, Inc., Watertown, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 31/53 (2006.01); A61K 31/50 (2006.01); A61K 31/496 (2006.01); A61K 31/497 (2006.01); A61K 31/517 (2006.01); A61K 31/505 (2006.01); A61K 31/4427 (2006.01); A61K 31/44 (2006.01); C07D 413/02 (2006.01); C07D 413/14 (2006.01); C07D 401/02 (2006.01); C07D 241/36 (2006.01); C07D 471/00 (2006.01); C07D 215/00 (2006.01); C07D 405/02 (2006.01);
U.S. Cl.
CPC ...
Abstract

5- and 6-membered heterocyclic compounds which are inhibitors of phosphodiesterase 10 are described as are processes, pharmaceutical compositions, pharmaceutical preparations and pharmaceutical use of the compounds in the treatment of mammals, including human(s) for central nervous system (CNS) disorders and other disorders which may affect CNS function. Also described is the treatment of neurological, neurodegenerative and psychiatric disorders including but not limited to those comprising cognitive deficits or schizophrenic symptoms.


Find Patent Forward Citations

Loading…